drugset / Trial / NCT06102863

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

NCT06102863

RandomizedParallel-groupOpen-labelTreatment

Summary

To explore the treatment efficacy of Progesterone Therapeutic Regimen Plus Statins in patients with atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EEC) for conservative treatment.

Timeline

Start
2023-04-01
Primary completion
2025-08-01
Completion
2025-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg Oral
Subject Rosuvastatin Small molecule 5 mg Oral
Subject pivastatin Unknown 2 mg Oral

Indications